Medical Devices

Philips (NYSE: PHG) has revealed the appointment of Jie Xue as the new chief business leader for Precision Diagnosis and Özlem Fidanci as the head of the international region. These appointments were made effective as of January 1. Xue and […]

Onward Medical announced today that it has commenced the inaugural sales of its ARC-EX spinal cord stimulation system in the U.S. This milestone sale follows less than a month after the Eindhoven-based company secured FDA clearance for the system. The

Qure.ai has announced Jim Mercadante, a seasoned veteran with 25 years in the medtech industry, as their new chief commercial officer (CCO). Bringing a wealth of experience in artificial intelligence, medical devices, and the broader medtech sector, Mercadante’s new role

Mendaera announced today the appointment of surgical robotics expert Eric Davidson as its inaugural chief commercial officer (CCO). Davidson will spearhead the company’s commercial strategies as it gears up to launch its groundbreaking robotic solutions. Based in San Mateo, California,

Johnson & Johnson MedTech (NYSE: JNJ) announced a provisional halt to U.S. Varipulse cases and evaluations. The company decided to pause activities on January 5th, driven by an extreme precautionary approach, after identifying four neurovascular incidents in the U.S. evaluations.

AerWave made an announcement today about successfully completing its initial human feasibility study for its innovative ultrasound-based lung denervation therapy, aimed at modifying disease progression. Hailing from New York, AerWave has also managed to secure $12 million in funding to

Today, Karl Storz announced its acquisition of the medical division from T1V, a company known for its visual collaboration software. This acquisition builds on their long-term collaboration with T1V as they expand the CollaboratOR portfolio. Karl Storz states that this

Kuros Biosciences USA has recently revealed a significant five-year exclusive sales agency collaboration with Medtronic, aimed at promoting the use of its MagnetOs bone graft technology. Kuros Biosciences USA — a fully owned subsidiary of Kuros Biosciences AG (headquartered in

Zeto today revealed the successful completion of a $31 million funding round aimed at enhancing its AI-powered EEG brain monitoring solutions. MindWorks Global (MWG) spearheaded this investment. The funds will aid in bolstering Zeto’s commercial and operational teams while fueling

Boston Scientific (NYSE: BSX) announced its intention to acquire Bolt Medical, a developer of intravascular lithotripsy (IVL) platforms. Before considering any existing equity stake and potential adjustments, the acquisition is set at $600 million upfront, with an additional $300 million